This inventor holds 1 USPTO granted patent. Top assignee: Oregon Health & Science University. Active years: 1998.
Company Filing History:
Years Active: 1998
Title: The Innovations of Frederick James Monsma
Introduction
Frederick James Monsma is a notable inventor based in Riehen, Switzerland. He has made significant contributions to the field of pharmacology, particularly in the area of opioid receptor research. His work has implications for both diagnostic and therapeutic applications.
Latest Patents
Monsma holds a patent for a novel mammalian opioid receptor ligand and its uses. This invention relates to the isolation, characterization, and pharmacological use of an endogenous ligand that specifically binds to a newly identified mammalian opioid receptor protein. The patent details the isolated peptide ligand and its analogues, derivatives, and variants. It also includes tyrosine substitution variants of the peptide ligand that can be radioiodinated. Furthermore, the patent outlines methods for creating these peptide ligands and their applications in identifying other naturally occurring or synthetic opioid receptor ligands.
Career Highlights
Monsma is affiliated with Oregon Health & Science University, where he has contributed to various research initiatives. His work has advanced the understanding of opioid receptors, which are crucial for developing new pain management therapies.
Collaborations
Monsma has collaborated with notable colleagues, including David K Grandy and James R Bunzow. These partnerships have enhanced the research and development of opioid receptor ligands.
Conclusion
Frederick James Monsma's innovative work in opioid receptor research has the potential to impact therapeutic practices significantly. His contributions to the field are noteworthy and continue to influence ongoing research in pharmacology.